The Canadian Press 17/06/2024 04:00 Many people with diabetes in Canada will soon be able to take insulin once a week instead of daily, drug manufacturer Novo Nordisk announced on Monday. Insulin icodec, which will be sold under the brand name Awiqli, is the first once-a-week basal insulin injection in the world and it will be available across the country starting June 30, the company told The Canadian Press ahead of the announcement. Canada is the first country to get the product, which was approved by Health Canada in March for the treatment of adults with Type 1 and Type 2 diabetes. “I think it’s a very big deal,” said Dr. Harpreet Bajaj, head of the clinical practice guidelines steering committee at Diabetes Canada. “(It’s) huge for reducing the burden…
Register
